- Home
- ORMP vs ALEC Comparison
ORMP vs ALEC Comparison
Compare ORMP & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- ALEC
- Stock Information
- Founded
- ORMP 2002
- ALEC 2013
- Country
- ORMP United States
- ALEC United States
- Employees
- ORMP N/A
- ALEC N/A
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ORMP Health Care
- ALEC Health Care
- Exchange
- ORMP Nasdaq
- ALEC Nasdaq
- Market Cap
- ORMP 104.6M
- ALEC 124.0M
- IPO Year
- ORMP N/A
- ALEC 2019
- Fundamental
- Price
- ORMP $2.21
- ALEC $1.27
- Analyst Decision
- ORMP
- ALEC Hold
- Analyst Count
- ORMP 0
- ALEC 9
- Target Price
- ORMP N/A
- ALEC $3.40
- AVG Volume (30 Days)
- ORMP 135.0K
- ALEC 5.4M
- Earning Date
- ORMP 11-07-2025
- ALEC 11-06-2025
- Dividend Yield
- ORMP N/A
- ALEC N/A
- EPS Growth
- ORMP N/A
- ALEC N/A
- EPS
- ORMP N/A
- ALEC N/A
- Revenue
- ORMP $2,000,000.00
- ALEC $69,048,000.00
- Revenue This Year
- ORMP N/A
- ALEC N/A
- Revenue Next Year
- ORMP N/A
- ALEC $314.69
- P/E Ratio
- ORMP N/A
- ALEC N/A
- Revenue Growth
- ORMP N/A
- ALEC 12.26
- 52 Week Low
- ORMP $1.82
- ALEC $0.87
- 52 Week High
- ORMP $3.09
- ALEC $6.14
- Technical
- Relative Strength Index (RSI)
- ORMP 38.97
- ALEC 25.95
- Support Level
- ORMP $2.30
- ALEC $1.45
- Resistance Level
- ORMP $2.40
- ALEC $1.34
- Average True Range (ATR)
- ORMP 0.11
- ALEC 0.15
- MACD
- ORMP -0.02
- ALEC -0.06
- Stochastic Oscillator
- ORMP 33.33
- ALEC 4.52
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.